Bovine apolipoprotein B-100 is a dominant immunogen in therapeutic cell populations cultured in fetal calf serum in mice and humans

Blood

Volumn 110, Issue 2, 2007, Pages 501-508

  Sakamoto, Norihisa ^a   Tsuji, Kazuhide ^a,b   Muul, Linda M ^c   Lawler, Ann M ^d   Petricoin, Emanuel F ^e   Candotti, Fabio ^c   Metcalf, Julia A ^f   Tavel, Jorge A ^f   Lane, H Clifford ^f   Urba, Walter J ^g   Fox, Bernard A ^g   Varki, Ajit ^h   Lunney, Joan K ⁱ   Rosenberg, Amy S ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^b OKAYAMA UNIVERSITY   (Japan)

^c NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e GEORGE MASON UNIVERSITY   (United States)

^f NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^g EARLE A CHILES RESEARCH INSTITUTE   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ AGRICULTURAL RESEARCH SERVICE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B100; LOW DENSITY LIPOPROTEIN RECEPTOR; MONOCLONAL ANTIBODY; POLYCLONAL ANTIBODY;

ADVERSE OUTCOME; ANIMAL CELL; ANTIBODY RESPONSE; ARTICLE; CELL POPULATION; CELL THERAPY; CONTROLLED STUDY; CULTURE MEDIUM; EMBRYO; EMBRYONIC STEM CELL; ENGRAFTMENT; EXPERIMENTAL MOUSE; FEMALE; FETAL CALF SERUM; HUMAN; HUMAN CELL; HUMAN VERSUS ANIMAL COMPARISON; HYPERSENSITIVITY REACTION; IMMUNE RESPONSE; MOUSE; NONHUMAN; PEPTIDE ANALYSIS; PRIORITY JOURNAL;

EID: 34547113105     PISSN: 00064971     EISSN: 00064971     Source Type: Journal    
DOI: 10.1182/blood-2007-01-066522     Document Type: Article

References (35)

1. D'Amour K, Gage FH. New tools for human developmental biology. Nat Biotechnol. 2000;8:381-382.
2. Thomson JA, Itskovitz-Eldor J, Shapiro SS, et al. Embryonic stem cell lines derived from human blastocysts. Science. 1998;282:1145-1147.
3. Bradley JA, Bolton EM, Pedersen RA. Stem cell medicine encounters the immune system. Nat Rev Immunol. 2002;2:859-871.
4. Swijnenburg RJ, Tanaka M, Vogel H, et al. Embryonic stem cell immunogenicity increases upon differentiation after transplantation into ischemic myocardium. Circulation. 2005;112:I166-172.
5. Drukker M, Benvenisty N. The immunogenicity of human embryonic stem-derived cells. Trends Biotechnol. 2004;22:136-141.
6. Selvaggi TA, Walker RE, Fleisher TA. Development of antibodies to fetal calf serum with arthus-like reactions in human immunodeficiency virus-infected patients given syngeneic lymphocyte infusions. Blood. 1997;89:776-779.
7. Mackensen A, Drager R, Schlesier M, Mertelsmann R, Lindemann A. Presence of IgE antibodies to bovine serum albumin in a patient developing anaphylaxis after vaccination with human peptide-pulsed dendritic cells. Cancer Immunol Immunother. 2000;49:152-156.
8. Tuschong LM, Soenen SL, Blease RM, Candotti F, Muul LM. Immune response to fetal calf serum by two adenosine deaminase-deficient patients after T cell gene therapy. Hum Gene Ther. 2002;13:1605-1610.
9. Muul LM, Tuschong LM, Soenen SL, et al. Persistence and expression of adenosine deaminase gene for 12 years and immune reaction to gene transfer components: long-term results of the first clinical gene therapy trial. Blood. 2003;101:2563-2569.
10. Maria JM, Alysson M, Gage F, Varki A. Human embryonic stem cells express an immunogenic nonhuman sialic acid. Nat Med. 2005;11:228-232.
11. Chambers I, Smith A. Self-renewal of teratocarcinoma and embryonic stem cells. Oncogene. 2004;23:7150-7160.
12. Solter D, Knowles BB. Monoclonal antibody defining a stage-specific mouse embryonic antigen (SSEA-1). Proc Natl Acad Sci U S A. 1978;75:5565-5569.
13. Tangvoranuntakul P, Gagneux P, Diaz S, et al. Human uptake and incorporation of an immunogenic nonhuman dietary sialic acid. Proc Natl Acad Sci U S A. 2003;100:12045-12050.
14. Walker RE, Carter CS, Muul L, et al. Peripheral expansion of pre-existing mature T cells is an important means of CD4+ T cell regeneration HIV-infected adults. Nat Med. 1998;4:852-856.
15. Dols A, Smith JW, Meijer SL, et al. Vaccination of women with metastatic breast cancer, using a costimulatory gene (CD80)-modified, HLA-A2-matched, allogeneic, breast cancer cell line: clinical and immunological results. Hum Gene Ther. 2003;14:1117-1123.
16. Tian L, Catt JW, O'Neill C, King NJ. Expression of immunoglobulin superfamily cell adhesion molecules on murine embryonic stem cells. Biol Reprod. 1997;57:561-568.
17. Madsen EM, Lindegaard ML, Andersen CB, Damm P, Nielsen LB. Human placenta secretes apolipoprotein B-100-containing lipoproteins. J Biol Chem. 2004;279:55271-55276.
18. Hevonoja T, Pentikainen MO, Hyvonen MT, Kovanen PT, Ala-Korpela M. Structure of low density lipoprotein (LDL) particles: Basis for understanding molecular changes in modified LDL. Biochim Biophys Acta. 2000;1488:189-210.
19. Howell BW, Herz J. The LDL receptor gene family: signaling functions during development. Curr Opin Neurobiol. 2001;11:74-81.
20. Gustafsson M, Borén J. Mechanism of lipoprotein retention by the extacellular matrix. Curr Opin Lipidol. 2004;15:505-514.
21. Chung NS, Wasan M. Potential role of the low-density lipoprotein receptor family as mediators of cellular drug uptake. Adv Drug Deliv Rev. 2004;56:1315-1334.
22. Dols A, Meijer SL, Hu HM, et al. Identification of tumor-specific antibodies in patients with breast cancer vaccinated with gene-modified allogeneic tumor cells. J Immunother. 2003;26:163-170.
23. Forni G, Green I. Heterologous sera: A target for in vitro cell-mediated cytotoxicity. J Immuno. 1976;116:1561-1565.
24. Lauer SJ, Finlan J, Borella LD, Piaskowski VD, Casper JT. In vitro enhancement of peripheral blood mononuclear cell natural killer activity following short term incubation with fetal calf serum. J Clin Lab Immunol. 1983;12:105-110.
25. Fogel M, Segal S, Gorelik E, Feldman M. Specific cytotoxic lymphocytes against syngeneic tumors are generated in culture in the presence of syngeneic, but not xenogeneic, serum. Int J Cancer. 1978;22:329-334.
26. Benatuil L, Kaye J, Rich RF, Fishman JA, Green WR, Iacomini J. The influence of natural antibody specificity on antigen immunogenicity. Eur J Immunol. 2005;35:2638-47.
27. Huber SA, Stone JE, Wagner DH, et al. Gamma delta+ T cells regulate major histocompatibility complex class II (IA and IE)-dependent susceptibility to coxsackievirus B3-induced autoimmune myocarditis. J Virol. 1999;73:5630-5636.
28. Horwitz EM, Gordon PL, Koo WK, et al. Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implication for cell therapy of bone. Proc Natl Acad Sci U S A. 2002;99:8932-8937.
29. Berger MG, Veyrat-Masson R, Rapatel C, Descamps S, Chassagne J, Boiret-Dupre N. Cell culture medium composition and translational adult bone marrow-derived stem cell research. Stem Cell. 2006;24:1409-1410.
30. Müller I, Kordowich S, Holzwarth C, et al. Animal serum-free culture conditions for isolation and expansion of multipotent mesenchymal stromal cells from human BM. Cytotherapy. 2006;8:437-444.
31. Yamaguchi M, Hirayama F, Wakamoto S, et al. Bone marrow stromal cells prepared using AB serum and bFGF for hematopoietic stem cells expansion. Transfusion. 2002;42:921-927.
32. Chen M, Li Y-G, Zhang D-Z, et al. Therapeutic effect of autologous dendritic cell vaccine on patients with chronic hepatitis B: A clinical study. World J Gastroenterol. 2005;11: 1806-1808.
33. Berg K, Powell LM, Wallis SC, Pease R, Knott TJ, Scott J. Genetic linkage between the antigenic group (Ag) variation and the apolipoprotein B gene: Assignment of the Ag locus. Proc Natl Acad Sci U S A. 1986;83:7367-7370.
34. Wu MJ, Bütler E, Bütler R, Schumaker VN. Identification of the base substitution responsible for the Ag(x/y) polymorphism of apolipoprotein B-100. Arterioscler Thromb. 1991;11:379-384.
35. Bardor M, Nguyen DH, Diaz S, Varki A. Mechanism of uptake and incorporation of the nonhuman sialic acid N-glycolylneuraminic acid into human cells. J Biol Chem. 2005;280:4228-4237.